Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer
Researchers at The University of Texas MD Anderson Cancer Center have discovered that adolescent and young adult (AYA) cancer survivors of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) have reduced long-term survival rates compared to their peers without cancer. The study also found inferior long-term mortality outcomes persist as far out as three decades into survivorship.
The findings, published today in...
Active Living After Cancer program improves physical functioning of breast cancer survivors
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program, markedly increased their...
Strike out cancer and celebrate survivorship at the ballpark
A double-header of cancer prevention and Chihuahuas baseball is in store for El Pasoans as experts from The University of Texas MD Anderson...
Lymphoma/Myeloma symposium for patients and caregivers set for Jan. 9
MD Anderson News Release 12/10/2015
Patients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming symposium to be held Jan. 9 in Houston.
The event, “Lymphoma/Myeloma Update for Patients: What’s New for 2016?” will take place at the Omni Houston Westside, 13210 Katy Freeway. The symposium is presented by The University of Texas MD Anderson Cancer...
Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence risk
MD Anderson study definitively links depression to outcome
MD Anderson News Release 12/03/2015
Depression is a significant...
Yin and yang: Immune signaling protein has opposing roles in breast cancer development
MD Anderson study reveals the function of TLR4 in cancer growth depends on TP53 mutation
MD Anderson News Release 06/08/2015
...
ASCO honors Allison for achievements in cancer immunotherapy
MD Anderson News Release 05/29/2015
The world’s leading organization of oncologists will honor Jim Allison, Ph.D., for his pioneering...